Pier 1 Imports (PIR) Declares $0.07 Quarterly Dividend; 6.6% Yield

Jefferies Raises price Target on Pier 1 Imports (PIR) Following 2Q Report

Jefferies reiterated a Hold rating on Pier 1 Imports (NYSE: PIR), and raised the price target to $4.50 (from $4.25), following the company's 2Q earnings report. Merchandise margins were in line with guidance on a more balanced promotional posture and improved distribution center efficiency.

Analyst... More

BTIG Keeps 'Sell' Rating on Pier 1 Imports (PIR); Says Activist Investor Doesn't Change Fundamental Issues

BTIG affirms Pier 1 Imports (NYSE: PIR) at Sell with a price target of $3.50 following Q2 results issued Wednesday night.

The firm commented today: We remain below guidance and the Street for 3Q16 and the all-important fourth quarter. PIR expects adj. 3Q EPS of... More

Pier 1 Imports (PIR) Reports In-Line Q2 EPS; Comps Fall 4.3%

Pier 1 Imports (NYSE: PIR) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $405.8 million versus the consensus estimate of $406.96 million.

Company comparable sales for the quarter decreased 4.3%.

GUIDANCE:

Pier 1 Imports sees Q3 2017 EPS of $0.09-$0.15, versus the consensus of $0.12.

Pier 1 Imports sees Q4 2017 EPS of $0.24-$0.32.

lex W. Smith,... More

Alden 'Disappointed' in Pier 1 Imports' (PIR) Adoption of 10% Poison Pill

Alden Global Capital LLC , the largest active shareholder of Pier 1 Imports, Inc. (NYSE: PIR), with ownership of approximately 9.5% of Pier 1's outstanding shares, issued a statement today in response to Pier 1's post-market announcement on September 27, 2016 that it has adopted a "poison pill" rights plan (the "Poison Pill") with a 10% ownership limitation. Alden is severely disappointed that Pier 1 has resorted to this highly questionable form of entrenchment rather than engage constructively with one of its largest shareholders.

Heath Freeman, President of Alden, stated, "We were incredibly surprised and disappointed to learn... More